Input of Medical Interventions, Medical Technologies, and Accessibility Factors in Lung Cancer Treatment Outcomes

Authors

  • Dmitry Meshkov V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Alexey Lobanov V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Anna Dzebisashvili V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Elena Makosko V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Polina Lysova V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Viktor Glebov V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Yana Matkovskaya V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia; Financial University under the Government of the Russian Federation, Moscow, Russia
  • Yuri Sidelnikov V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia; Moscow Aviation Institute (National Research University), Moscow, Russia
  • Olga Rodionova V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Sergey Cherkasov V.A. Trapeznikov Institute of Control Science of the Russian Academy of Sciences, Moscow, Russia
  • Ludeña Moreira Genesis Marley Peoples’ Friendship University of Russia named after Patrice Lumumba, Moscow, Russia
  • Andrey Podoynitsin AbbVie LLC (the Russian division of AbbVie), Moscow, Russia
  • Aleksandr Sumin The “Roscongress” foundation, Moscow, Russia

DOI:

https://doi.org/10.25728/assa.2026.26.1.2096

Keywords:

Accessibility, affordability, Acceptability, Availability, multiagent active system model, safety, medical technology, intervention, efficacy

Abstract

Expert analysis reveals that outcomes in lung cancer treatment involving novel drugs depend less on the drugs themselves and more on systemic changes in disease management. These outcomes are tied to key acceptability factors: patient awareness and perceptions regarding early diagnosis and adherence, awareness and qualifications of healthcare providers (HCPs), and overall affordability and availability. Consequently, a rational model for disease control must consider medical technology as a multi-agent integrated system. This complex must include both the medical intervention (the drug) and the critical accessibility factors that ensure treatment success, ultimately transforming the underlying healthcare infrastructure, financing, and specialist expertise.

Downloads

Published

2026-03-01

Issue

Vol. 26 No. 1 (2026): Advances in Systems Science and Applications

Section

Articles

How to Cite

Input of Medical Interventions, Medical Technologies, and Accessibility Factors in Lung Cancer Treatment Outcomes. (2026). Advances in Systems Science and Applications, 26(1), 118-126. https://doi.org/10.25728/assa.2026.26.1.2096

Most read articles by the same author(s)